Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

Also called NCT06212674

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06212674
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06212674. Randomized; no masking; primary purpose other. Start 2025-10-31 (actual); primary completion 2027-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
Acronym
PILOS-AF
Intervention (Procedure)
PVI + LAAO, single stage
Intervention (Procedure)
LAAO
Intervention (Drug)
NOAC
Lead sponsor
Medical University of Silesia (class: other)
Collaborator
Medical University of Lodz (class: other)
Collaborator
Silesian Centre for Heart Diseases (class: other)
Collaborator
Pomeranian Medical University Szczecin (class: other)
Collaborator
American Heart of Poland (class: other)
Collaborator
Leszek Giec Upper-Silesian Medical Centre (class: not stated)

Record details

Record id
cardio:ct-nct06212674
Content hash
f5f0adc15bc0587629ee29c7150f0d63694103a29a07c3a2ee75653a4fab48ee